Access Scientific, Inc. has received FDA clearance for its MicroAccess WAND(R), the world’s first all-in-one safety introducer. This sophisticated new medical device enables clinicians to more quickly and safely insert a sheath or catheter into the peripheral vasculature.
The MicroAccess WAND is the first of several planned WAND devices from Access Scientific to receive FDA clearance. The devices combine all components of the older, Modified Seldinger Technique into a unitary device that provides faster, safer, simpler over-wire vascular access.
“The MicroAccess WAND is the first device to enable clinicians to perform the Accelerated Seldinger Technique, which we believe is the ultimate refinement in vascular access technology,” said Steve Bierman, M.D., CEO of Access Scientific. “FDA clearance of the first version of The WAND marks a major step forward in making the Accelerated Seldinger Technique available to clinicians.”
The first clinical sites will begin using the device immediately, Dr. Bierman said, now that it has received FDA clearance.
Click here for the full press release.